Avalo Therapuetics (AVTX) Misses Q2 EPS by 1407c
Tweet
Share
E-mailGet Alerts AVTX Hot Sheet
Join SI Premium – FREE
Avalo Therapuetics (NASDAQ: AVTX) reported Q2 EPS of ($14.07).
For earnings history and earnings-related data on Avalo Therapuetics (AVTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Starts Tier IV Inc (593A:JP) at Overweight
- Morgan Stanley Downgrades PWR Holdings Ltd. (PWH:AU) to Equalweight
- Is the global equity rally broadening? UBS weighs in
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
